A recent webinar highlighted a really important collaboration between our team in Bend and scientists at the Access to Advanced Health Institute (AAHI) in Seattle. They’ve been looking to develop a nasal dry powder formulation of a vaccine for tuberculosis. As such a vaccine would be shelf-stable, it could be an incredibly important tool for preventing infection in developing countries, where cold-chain distribution of vaccines is a challenge. Sana Hosseini, Ph.D. and Kimberly Shepard from Bend gave the webinar alongside AAHI’s John Chen. They explained how spray drying – a key technique used by Lonza for making dry powders – can be used to make the formulation, and how it behaves within a nasal inhalation device. The webinar is now available to watch on demand, so if you missed it live, you can now catch up with it here. https://lnkd.in/eUFewpmN #LonzaSM #dpi #inhalation
Hlo SAR
Interesting event
Vivek BSc
2wHlo